GlassScriptPhysician profile
James P Townson
NPI 1699039800
$4,489.85
in general payments reported to CMS, 2019-2025
26 companies · $532 in 2025
The $532 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.78 · 2020: $111 · 2021: $2,974 · 2022: $263 · 2023: $243 · 2024: $317 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.25 |
| Long Term Medical Supply Or Device Loan | $147.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,305.34 | 2021-2025 | |
| Medinc of Texas | $1,200.00 | 2021 | |
| Medtronic, INC. | $335.90 | 2021-2025 | Inceptiv, Vanta Adaptivestim, Primeadvanced Surescan |
| Horizon Therapeutics Plc | $240.92 | 2020-2021 | |
| Integra Lifesciences Corporation | $190.98 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Alfasigma USA, INC. | $184.24 | 2021 | |
| Organogenesis INC. | $174.45 | 2022-2025 | Affinity, Novachor |
| Treace Medical Concepts, INC. | $159.46 | 2022-2024 | |
| Bioventus LLC | $118.21 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $87.02 | 2022-2025 | Proclaim, Eterna, Octrode |
| Stryker Corporation | $66.96 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $55.89 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $47.82 | 2021-2024 | Zilretta, Iovera, Exparel |
| Smith+Nephew, INC. | $38.95 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Solventum Corporation | $37.20 | 2025 | Activ.A.C. |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $33.53 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Melinta Therapeutics, LLC | $30.90 | 2019-2020 | |
| Mimedx Group, INC. | $30.62 | 2025 | |
| Biotronik Nro, INC. | $25.99 | 2025 | Prospera |
| Boston Scientific Corporation | $25.71 | 2024 | |
| Wright Medical Technology, INC. | $23.35 | 2019 | |
| Hartmann USA, INC. | $18.93 | 2025 | Zetuvit Plus 10x10 P10 |
| Medtronic Vascular, INC. | $16.67 | 2020 | |
| Tactile Systems Technology INC | $13.64 | 2025 | Flexitouch Plus, Nimbl |
| Xeris Pharmaceuticals, INC. | $13.63 | 2025 | Keveyis |
| Merck Sharp & Dohme LLC | $13.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Townson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.